ENGLISH
 
简体中文
 
                 
 
  新闻类别
行业动态
预警分析
案件应对
预警工作
展会信息
行业新闻
企业新闻
 
 
行业动态
欧盟重新评估蔗糖脂肪酸酯作为16周以下婴儿食品添加剂的安全性
  • 作者:   来源:江苏汉光甜味剂有限公司    时间:2023/4/24    点击:220
2023年4月21日,据欧盟食品安全局EFSA )消息,欧盟食品添加剂调味剂小组(FAF)重新评估蔗糖脂肪酸酯(sucrose esters of fatty acids)(E 473)作为16周以下婴儿食品添加剂的安全性,并对其作为食品添加剂用于所有人群进行了后续评估。
 
  部分原文报道如下:
 
  Sucrose esters of fatty acids (E 473) was re-evaluated in 2004 by the former EFSA Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC Panel). In addition, the former EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS Panel) issued scientific opinions on the safety of sucrose esters of fatty acids (E 473) in 2010, 2012 and 2018. As a follow-up to these assessments, the Panel on Food Additives and Flavourings (FAF) was requested to assess the safety of sucrose esters of fatty acids (E 473) for its uses as food additive in food for infants below 16 weeks of age. In addition, the FAF Panel was requested to address the issues already identified by the EFSA AFC and ANS Panels when used in food for the general population. The process involved the publication of calls for data to allow the interested business operators to provide the requested information to complete the risk assessment. The Panel concluded that the technical data provided by the interested business operators support an amendment of the specifications for sucrose esters of fatty acids (E 473) laid down in Commission Regulation (EU) No 231/2012. According to the available information, E 473 is not used in food categories (FCs) 13.1.1 and 13.1.5.1, including all types of food for infants below 16 weeks of age, and in FC 13.1.5.2. As a consequence, an assessment of the safety for the uses of E 473 as food additive in these FCs and age group was not performed. When the updated exposure estimates considering the provided use levels for some food categories are taken into account the estimates of exposure to sucrose esters of fatty acids (E 473) exceeded the group acceptable daily intake (ADI) of 40?mg/kg body weight (bw) per day for many population groups.